Check out our most popular compounded medications! Get Started
Temozolomide is an oral alkylating agent primarily used in the treatment of certain types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma.
Temozolomide is an oral alkylating agent primarily used in the treatment of certain types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma. It functions by interfering with the DNA replication process in cancer cells, ultimately leading to cell death and tumor shrinkage. This mechanism of action makes Temozolomide a critical component in oncology, particularly for patients who have not responded to other treatments.
Due to its ability to cross the blood-brain barrier, Temozolomide is especially effective in targeting brain tumors, offering a therapeutic advantage over other chemotherapeutic agents. It is often used in combination with radiotherapy to enhance its efficacy, providing a synergistic effect that improves patient outcomes. The dosing regimen of Temozolomide is typically tailored to the individual patient's needs, taking into account factors such as the type and stage of the tumor, as well as the patient's overall health and response to treatment.
Temozolomide is generally well-tolerated, but like all chemotherapeutic agents, it can cause side effects. Common adverse effects include nausea, vomiting, fatigue, and myelosuppression, which necessitates regular monitoring of blood counts during treatment. Understanding the pharmacokinetics and potential interactions of Temozolomide is crucial for healthcare providers to optimize its use and manage any side effects effectively.
In the context of compounding, Temozolomide can be formulated into various dosage forms to meet specific patient needs, enhancing its accessibility and ease of administration. This flexibility is particularly beneficial for patients who may have difficulty swallowing tablets or require a tailored dosage form due to unique clinical circumstances. As a result, compounded formulations of Temozolomide play a vital role in personalized cancer care, ensuring that patients receive the most appropriate and effective treatment for their condition.
Each of these is compounded to order at our Warwick, Rhode Island pharmacy and requires a prescription.
We do not have a patient page for this ingredient yet. That does not mean we cannot make it. Bayview compounds this ingredient to a prescriber's order, and our full compounding formulary lists every preparation we make. Viewing the formulary requires a prescriber account.
Prescriber sign inA sample of preparations from our formulary. Strengths and dose forms are customised to the prescription.
Other salt forms of this molecule, and ingredients commonly compounded alongside it.
This page describes an active pharmaceutical ingredient, not a finished drug product. Bayview Pharmacy compounds preparations containing it only on a prescriber's order for an individual patient.
Compounded preparations are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. Nothing on this page is a claim that any preparation is effective for any condition.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Our pharmacists work with prescribers to build preparations around a patient's dose, form and tolerances. Ask us what is possible with this ingredient.
